| Aug 13 2026 |
Food & Chemicals Unpacked- The Nicotine Scene: PMTAs, Pouches, and Policy [Podcast] |
Keller and Heckman LLP |
| Aug 12 2026 |
This Week in 340B: July 27 – August 10, 2026 |
McDermott Will & Schulte LLP |
| Aug 12 2026 |
Bill Introduced into House Would Require Allergen Labeling for Gluten-containing Grains |
Keller and Heckman LLP |
| Aug 12 2026 |
What Strawberries Can Teach Us About the Next Wave of PFAS Litigation |
CMBG3 Law |
| Aug 11 2026 |
Court of Federal Claims Reaffirms Agency Discretion in TAA Country-of-Origin Determinations for Pharmaceuticals |
Blank Rome LLP |
| Aug 11 2026 |
FDA Posts Caffeine Disclosure Citizen Petition |
Keller and Heckman LLP |
| Aug 11 2026 |
CMS, FDA Propose RAPID Pathway for Medicare Coverage of Certain Medical Devices |
Polsinelli PC |
| Aug 10 2026 |
OIRA Completes Review of FDA Proposed GRAS Rule |
Keller and Heckman LLP |
| Aug 10 2026 |
CODEX ALIMENTARIUS – Main Outcome of the 49th Meeting of the Codex Alimentarius Commission (CAC49) |
Keller and Heckman LLP |
| Aug 7 2026 |
FDA Denies Request for Public Hearing on Repeal of Authorizations for FD&C Red No. 3 |
Keller and Heckman LLP |
| Aug 7 2026 |
Ninth Circuit Partially Revives ‘Low-FODMAP’ Labeling Suit |
Keller and Heckman LLP |
| Aug 6 2026 |
Above the Federal Floor: How States Are Regulating Compounded GLP-1s and Peptides |
Sheppard, Mullin, Richter & Hampton LLP |
| Aug 6 2026 |
TMA Chicago/Midwest Podcast | Navigating Distress in Wine and Spirits and Driving Durable Value: A Conversation With Bernardo Silva [Podcast] |
Katten |
| Aug 6 2026 |
What the FDA's Botox Warning Letter Means for DSCSA Compliance [Podcast] |
K&L Gates LLP |
| Aug 5 2026 |
From EPA to Industry- Lessons Learned That Revolutionize Food and Chemical Safety — A Conversation with Susanna W. Blair, Ph.D. [Podcast] |
Bergeson & Campbell, P.C. |
| Aug 5 2026 |
Ohio Board of Pharmacy Extends Reporting Deadline for Theft or Significant Loss of Prescription Drugs |
Shumaker |
| Aug 4 2026 |
Walking the Line: Navigating AKS Risk in Pharmaceutical Speaker Programs and Patient Support |
Barnes & Thornburg LLP |
| Aug 4 2026 |
Pay Transparency + the Power of Preventive Strategies — Episode 3: Pivoting Toward Preparation in the Life Sciences [Video] |
Jackson Lewis P.C. |
| Aug 4 2026 |
Senators Introduce Food Labeling Modernization Act |
Keller and Heckman LLP |
| Aug 3 2026 |
Big Law Redefined: Digital Health Miniseries Episode 2 | Regulatory Strategy and Reimbursement Essentials for Digital Health and MedTech Companies in the EU Market [Podcast] |
Greenberg Traurig, LLP |
| Aug 3 2026 |
USDA’s 2026 Unified Agenda Includes Biobased Product and Biotechnology Rulemakings |
Bergeson & Campbell, P.C. |
| Aug 3 2026 |
From Code to Compliance: Decoding India’s Medical Device Software Guidance |
Nishith Desai Associates |
| Jul 31 2026 |
Ultra-Processed Food Manufacturers Face New Litigation Challenges in California and Beyond |
Greenberg Traurig, LLP |
| Jul 31 2026 |
The Intersection of MoCRA and Data Privacy |
Greenberg Traurig, LLP |
| Jul 30 2026 |
FTC and States Sue Hims & Hers Over Deceptive Health Data Sharing and Subscription Billing Practices |
Shumaker |
| Jul 30 2026 |
FDA Reopens Public Comment Period for Request for Information on BHT |
Keller and Heckman LLP |
| Jul 29 2026 |
FDA Committee Supports Peptide Compounding: What Comes Next for Compounders, Telehealth Platforms, Med Spas and Others |
Polsinelli PC |
| Jul 29 2026 |
Trip Advisor: FDA Publishes Guidance on Psychedelic Drug Trials |
Bradley Arant Boult Cummings LLP |
| Jul 29 2026 |
FDA’s Advisory Committee Votes on Peptides: What It Does and Doesn’t Do |
Mintz |
| Jul 29 2026 |
FDA Announces FY 2027 User Fee Rates for VQIP and TTP |
Keller and Heckman LLP |
| Jul 29 2026 |
FDA Continues Shift of Inspections to States and Development of AI Tools |
Keller and Heckman LLP |
| Jul 29 2026 |
Bipartisan Lawmakers Introduce Legislation to Enhance Foodborne Illness Monitoring |
Keller and Heckman LLP |
| Jul 28 2026 |
Food Regulation Developments: Struggles to Define Ultraprocessed Foods |
Beveridge & Diamond PC |
| Jul 28 2026 |
The Menopause Market Is Becoming Mainstream: What Employers, Providers, and Investors Need to Know Now |
Katten |
| Jul 27 2026 |
Cross-Border Catch-Up: Liberalization and Compliance—What’s Changing for Employers in the UAE [Podcast] |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
